The proportion of tumor-stroma as a strong prognosticator for stage II and III colon cancer patients: validation in the VICTOR trial.

The proportion of tumor-stroma as a strong prognosticator for stage II and III colon cancer patients: validation in the VICTOR trial.

BACKGROUND: The intra-tumor stroma percentage in colon cancer (CC) patients has previously been reported by our group as a strong independent prognostic parameter. Patients with a high stroma percentage within the primary tumor have a poor prognosis. PATIENTS AND METHODS: Tissue samples from the mo...

Bibliográfalaš dieđut
Váldodahkkit:	Huijbers, A, Tollenaar, R, v Pelt, G, Zeestraten, E, Dutton, S, McConkey, C, Domingo, E, Smit, V, Midgley, R, Warren, B, Johnstone, E, Kerr, D, Mesker, W
Materiálatiipa:	Journal article
Giella:	English
Almmustuhtton:	2013

Geahča maid

STROMA PRODUCTION WITHIN THE PRIMARY TUMOR CORRELATES WITH POOR SURVIVAL FOR STAGE I-II COLON CANCER PATIENTS.
Dahkki: Mesker, W, et al.
Almmustuhtton: (2010)

Stroma Production Within the Primary Tumour Correlates With Poor Survival for Stage I-II Colon Cancer Patients
Dahkki: Mesker, W, et al.
Almmustuhtton: (2011)

Stroma production within the primary tumour correlates with poor survival for stage I-II colon cancer patients
Dahkki: Mesker, W, et al.
Almmustuhtton: (2010)

STROMA PRODUCTION WITHIN THE PRIMARY TUMOR CORRELATES WITH POOR SURVIVAL FOR STAGE I-II COLON CANCER PATIENTS
Dahkki: Mesker, W, et al.
Almmustuhtton: (2010)

THE INTRA-TUMOR STROMA MICROENVIRONMENT IN THERAPY MANAGEMENT FOR COLON CANCER PATIENTS
Dahkki: Mesker, W, et al.
Almmustuhtton: (2012)

Filling the gap between microscopic and automated analysis of the tumor-stroma ratio
Dahkki: Gabi Pelt, et al.
Almmustuhtton: (2020-03-01)

Phase III randomized trial assessing rofecoxib in the adjuvant setting of colorectal cancer: final results of the VICTOR trial.
Dahkki: Midgley, R, et al.
Almmustuhtton: (2010)

VICTOR: A PHASE III PLACEBO-CONTROLLED TRIAL OF ROFECOXIB IN COLORECTAL CANCER PATIENTS FOLLOWING SURGICAL RESECTION
Dahkki: Midgley, R, et al.
Almmustuhtton: (2008)

VICTOR: A phase III placebo-controlled trial of rofecoxib in colorectal cancer patients following surgical resection
Dahkki: Kerr, D, et al.
Almmustuhtton: (2008)

The role of artificial intelligence to quantify the tumour-stroma ratio for survival in colorectal cancer
Dahkki: Marloes A Smit, et al.
Almmustuhtton: (2020-11-01)

e-Learning for Instruction and to Improve Reproducibility of Scoring Tumor-Stroma Ratio in Colon Carcinoma: Performance and Reproducibility Assessment in the UNITED Study
Dahkki: Smit, Marloes A, et al.
Almmustuhtton: (2021-03-01)

Deep learning based tumor–stroma ratio scoring in colon cancer correlates with microscopic assessment
Dahkki: Marloes A. Smit, et al.
Almmustuhtton: (2023-01-01)

The value of tumor-stroma ratio as predictor of pathologic response after neoadjuvant chemoradiotherapy in esophageal cancer
Dahkki: G.W. van Pelt, et al.
Almmustuhtton: (2020-01-01)

Combined Assessment of the Tumor–Stroma Ratio and Tumor Immune Cell Infiltrate for Immune Checkpoint Inhibitor Therapy Response Prediction in Colon Cancer
Dahkki: Cor J. Ravensbergen, et al.
Almmustuhtton: (2021-10-01)

Presence of a High Amount of Stroma and Downregulation of SMAD4 Predict for Worse Survival for Stage I–II Colon Cancer Patients
Dahkki: Wilma E. Mesker, et al.
Almmustuhtton: (2009-01-01)

High Tumor Stroma Proportion is a Worse Prognostic Factor in Colorectal Cancer
Dahkki: Josipa Flam, et al.
Almmustuhtton: (2017-01-01)

Histological Study of Human Thyroid Gland Relative Proportion of Parenchyma and Stroma in Thyroid Glands of Bangladeshi People
Dahkki: Md Enayet Ullah, et al.
Almmustuhtton: (2013-02-01)

The role of the tumor stroma in ovarian cancer
Dahkki: Ben eDavidson, et al.
Almmustuhtton: (2014-05-01)

FEATURES OF ENDOMETRIAL STROMA DECIDUALIZATION IN EARLY PREGNANCY LOSS
Dahkki: Luchko E. V., et al.
Almmustuhtton: (2018-12-01)

The hematopoietic stroma
Dahkki: N.B. Nardi, et al.
Almmustuhtton: (1999-05-01)

Nurturing the Positive Mental Health of Autistic Children, Adolescents and Adults alongside That of Their Family Care-Givers: A Review of Reviews
Dahkki: Roy McConkey
Almmustuhtton: (2023-11-01)

A Brief Measure of Parental Wellbeing for Use in Evaluations of Family-Centred Interventions for Children with Developmental Disabilities
Dahkki: Roy McConkey
Almmustuhtton: (2020-09-01)

Responding to Autism in Low and Middle Income Countries (Lmic): What to Do and What Not to Do
Dahkki: Roy McConkey
Almmustuhtton: (2022-10-01)

Supporting Families through Early Intervention
Dahkki: Roy McConkey
Almmustuhtton: (2003-09-01)

IRRODL is Growing!
Dahkki: Brigette McConkey
Almmustuhtton: (2009-02-01)

Immunosuppressive Phenotype of Esophagus Tumors Stroma
Dahkki: Olga V. Kovaleva, et al.
Almmustuhtton: (2020-01-01)

My Friend Victor
Dahkki: V. A. Soifer
Almmustuhtton: (2020-12-01)

The prognostic role of desmoplastic stroma in pancreatic ductal adenocarcinoma
Dahkki: Wang, L, et al.
Almmustuhtton: (2015)

CYTOKINE GENE EXPRESSION ASSOCIATED WITH TUMOR AND PREMETASTATIC NICHES IN BREAST CANCER STROMA
Dahkki: L. A. Tashireva, et al.
Almmustuhtton: (2016-12-01)

Colorectal carcinoma cells (Caco-2) secrete stroma-inducing growth factors in a stroma-oriented direction.
Dahkki: Wardelmann, E, et al.
Almmustuhtton: (2003)

Colorectal carcinoma cells (Caco-2) secrete stroma-inducing growth factors in a stroma-oriented direction
Dahkki: Wardelmann, E, et al.
Almmustuhtton: (2003)

The Role of the Stroma in Carcinogenesis
Dahkki: Nurija Bilalović, et al.
Almmustuhtton: (2006-02-01)

Editorial: Rising stars in parasite and host: 2023
Dahkki: Glenn A. McConkey
Almmustuhtton: (2024-12-01)

Tumor-stroma proportion is associated with increased M2 macrophage abundance and predicts the resistance to immune checkpoint blockade in breast cancer
Dahkki: Yincheng Liu, et al.
Almmustuhtton: (2025-04-01)

In Memory of Victor Alexandrovich Guruzhapov
Dahkki: Ermolaeva M.V., et al.
Almmustuhtton: (2020-12-01)

Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study.
Dahkki: Gray, R, et al.
Almmustuhtton: (2007)

Stroma cell priming in enteric lymphoid organ morphogenesis
Dahkki: Manuela eFerreira, et al.
Almmustuhtton: (2012-07-01)

Rofecoxib and cardiovascular adverse events in adjuvant treatment of colorectal cancer.
Dahkki: Kerr, D, et al.
Almmustuhtton: (2007)

Genetic prognostic and predictive markers in colorectal cancer.
Dahkki: Walther, A, et al.
Almmustuhtton: (2009)

Erratum: Genetic prognostic and predictive markers in colorectal cancer (Nature Reviews Cancer (2009) 9 (489-499))
Dahkki: Walther, A, et al.
Almmustuhtton: (2011)